Efficacy and Tolerability of Enstilar® in Daily Practice

Prospective, Observational, Non-interventional, Multicenter Study on the Efficacy and Tolerability of Calcipotriol/Betamethasone Aerosol Foam (Enstilar®) in Patients With Plaque Psoriasis Under Daily Practice Conditions

This study aims to assess how the Enstilar® aerosol foam performs in daily real-life practice with regards to effectiveness and convenience of application to psoriasis plaques on body and extremities. In addition the profiles of patients prescribed Enstilar® will be described, and preceeding, concomitant and follow-up management will be mapped. The study will be conducted in about 100 dermatology clinics all over Germany,

Inclusion Criteria:

• ≥ 18 years of age
• Psoriasis vulgaris
• Lesions on trunk and/or extremities of at least mild severity
• Treatment with Enstilar® planned
• Signed informed consent to participate

Exclusion Criteria:

• Enrolled in any interventional clinical trial
• Ongoing or recent treatment with any systemic psoriasis
• Ongoing or recent treatment with UV-therapy
• Ongoing or previous treatment with Enstilar®
• Psoriasis of scalp only
• Other forms of psoriasis, e.g. erythrodermic or pustular psoriasis
• More than 30% of surface area affected by psoriasis
• Any contraindications or known allergies to Enstilar® or its ingredients
• Incapacitated patients under institutionalized care